PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18285555-7	2008	Olmesartan treatment significantly ameliorated glomerulosclerosis and dramatically decreased urinary Smad1 (from 3.9 +/- 2.9 to 0.3 +/- 0.3 ng/mg creatinine, P < 0.05).	olmesartan	0-10	SMAD family member 1	Rattus norvegicus	101-106	
16767106-7	2006	Immunohistochemical staining and Western blotting showed that the increased expression of Smad1, phospho-Smad1, and phospho-Src was inhibited by olmesartan.	olmesartan	145-155	SMAD family member 1	Rattus norvegicus	90-95	
16767106-7	2006	Immunohistochemical staining and Western blotting showed that the increased expression of Smad1, phospho-Smad1, and phospho-Src was inhibited by olmesartan.	olmesartan	145-155	SMAD family member 1	Rattus norvegicus	105-110	
16767106-8	2006	Ang II induced Col4 synthesis and increased expression of phospho-Src and phospho-Smad1 in cultured mesangial cells, which was blocked by olmesartan.	olmesartan	138-148	SMAD family member 1	Rattus norvegicus	82-87